Therefore, we need more clinical studies and observations to confirm the alterations in IL-22 levels in patients with PCOS, as well as more effort to investigate the underlying mechanisms of the differences in IL-22 levels among various metabolic diseases. The gene discussed is IL22; the disease is metabolic disease.